Alpha Cognition Inc.
Nasdaq: ACOGBiological Products, (No Diagnostic Substances) · Entity-resolved by Clous
CIK0001655923
TickerACOG
ExchangeNasdaq
SIC2836
StateA1
FY end12-31
Key financials
RevenueFY2025-12-31
$10.22M
—
Net IncomeFY2025-12-31
-$20.67M
-41.2% YoY
Total AssetsFY2025-12-31
$79.73M
+57.1% YoY
EquityFY2025-12-31
$62.53M
+50.8% YoY
Shares OutstandingFY2025-12-31
21.77M
—
Operating Cash FlowFY2025-12-31
-$20.38M
-162.8% YoY
Market
Market
ACOGClose price
$6.93
Market cap
$150.89M
delayed EOD · as of 2026-06-18
Short interest & fails
Short-sale volume
FINRA Reg SHO · daily32.8%
short of total volume · 2026-06-18
2026-06-1832.8%
2026-06-1744.6%
2026-06-1611.7%
2026-06-1524.4%
2026-06-1248.5%
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
AI business summary — latest 10-K
Summary
No filing text provided to summarize.
What it means
Cannot determine significance without content.
What to watch
Await the complete filing text for analysis.
Generated from public filings · not investment advice
| Concept | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|
| Revenue | — | $10.22M | — | 100% |
| Net Income | -$14.64M | -$20.67M | -41.2% | -202% |
| Total Assets | $50.74M | $79.73M | +57.1% | 780% |
| Equity | $41.46M | $62.53M | +50.8% | 612% |
| Operating Cash Flow | -$7.76M | -$20.38M | -162.8% | -199% |
| Shares Outstanding | — | 21.77M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001655923